Teicoplanin use and emergence of Staphylococcus haemolyticus: is there a link?

Clin Microbiol Infect. 2006 Jan;12(1):96-7. doi: 10.1111/j.1469-0691.2005.01307.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-Infective Agents / pharmacology
  • Anti-Infective Agents / therapeutic use*
  • Antibiotic Prophylaxis
  • Bacteremia / drug therapy
  • Bacteremia / microbiology*
  • Bacteremia / prevention & control
  • Cross Infection / drug therapy
  • Cross Infection / microbiology*
  • Cross Infection / prevention & control
  • Drug Resistance, Bacterial*
  • Humans
  • Methicillin Resistance
  • Microbial Sensitivity Tests
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / prevention & control
  • Staphylococcus haemolyticus / drug effects*
  • Staphylococcus haemolyticus / isolation & purification
  • Teicoplanin / pharmacology
  • Teicoplanin / therapeutic use*

Substances

  • Anti-Infective Agents
  • Teicoplanin